Using real-time, high-resolution imaging, scientists have identified how a “doorway” in the blood vessel wall allows cancer cells to spread from breast tumours to other parts of the body.
The findings lend support to emerging tests that better predict whether breast cancer will spread, which could spare women from invasive and unnecessary treatments, and could lead to new anti-cancer therapies. The research, conducted by investigators at the NCI-designated Albert Einstein Cancer Center (AECC) and Montefiore Einstein Center for Cancer Care, utilized a mouse model of human breast cancer and mice implanted with human breast tissue. The study was published today in the online edition of Cancer Discovery.
The Einstein-Montefiore researchers previously found that breast cancer spreads when three specific cells are in direct contact: an endothelial cell (a type of cell that lines the blood vessels), a perivascular macrophage (a type of immune cell found near blood vessels), and a tumour cell that produces high levels of Mena, a protein that enhances a cancer cell’s ability to invade. The site where these three cells come in direct and stable contact—called a tumour microenvironment of metastasis, or TMEM—is where tumour cells enter blood vessels.
“It has been known for some time that blood vessels in tumours are abnormally permeable. But what regulates that permeability hasn’t been clear. Based on our latest imaging studies, we can now say that this phenomenon is regulated by TMEM macrophages,” said lead author Allison Harney, Bridge Postdoctoral Fellow in the Integrated Imaging Program at Albert Einstein College of Medicine.
This new research indicates that the TMEM macrophage releases a protein called vascular endothelial growth factor, or VEGF, which causes a local increase in blood vessel permeability. The effect is temporary but can last long enough to allow cancer cells to enter the blood stream—escaping the primary tumour and traveling to distant metastatic sites.
The researchers also observed for the first time that transient blood vessel permeability and tumour cell entry into the bloodstream occur simultaneously and exclusively at TMEM sites. The discovery was made using intravital high-resolution two-photon microscopy to image primary breast cancer tumours in mice and human xenografts (human breast cancer tissue grafted into mice).
“The discovery of a unique doorway that allows tumour cells into the blood stream opens new opportunities for the development of anti-metastasis therapeutics” said study leader John Condeelis, Ph.D., professor and co-chair of anatomy and structural biology, co-director of the Gruss Lipper Biophotonics Center and the Integrated Imaging Program, and the Judith and Burton P. Resnick Chair in Translational Research at Einstein and leader of the Tumour Microenvironment and Metastasis Program at AECC.
[hr] Source: Albert Einstein College of Medicine